University of Maryland consortium launches Institute for Health Computing

The University of Maryland Strategic Partnership announced this week a transformative partnership to establish the University of Maryland 3 Institute for Health Computing, or UM-3-IHC.

The effort is led by the University of Maryland, Baltimore, and the University of Maryland, College Park, in collaboration with the University of Maryland Medical System in Montgomery County, Maryland.

The goal is to utilize advances in artificial intelligence and machine learning to securely and de-identified and evaluate health data to diagnose, prevent, and treat disease in patients in the state of Maryland.

The new institute focuses on algorithms to enable precision patient care for diabetes, high blood pressure, risk of opioid overdose and other health risks.

“Scaling research to address grand challenges in the life sciences is about moving from collecting data to using state-of-the-art technology to uncover meaningful patterns hidden in the data,” said Darryll J. Pines, president of the University of Maryland, College Park, and a statement.

“This institute will tap world-class researchers exploring artificial intelligence, machine learning, and virtual and augmented reality to collaborate with medical experts, leading to broad impact on human health and well-being.”

Also Read :  Time to get spooky: An alien experience

Researchers will also explore how immersive and 5G wireless technologies can boost the availability and efficiency of telehealth, and how virtual and augmented reality over 5G networks can expand the diagnostic capabilities of clinicians.

The institute is expected to open in the leased space in early 2023, with the final completion of laboratory and office space in the North Bethesda metro area in 2028, officials say. Initial funding of $25 million is provided by MPower. Montgomery County government will provide an additional $ 40 million to develop the permanent site.

“We are witnessing an unprecedented revolution in healthcare, driven by biomedical innovation, the digitization of medical records, and advances in machine learning and artificial intelligence,” said UMB President Dr. Bruce E. Jarrell, in a statement. “This new institute will include all these elements in a synergistic effect that will transform our healthcare system.”

Also Read :  Airway Management Launches its Custom flexTAP with Pioneered Technology

The Maryland officials behind UM-3-IHC noted how North Bethesda’s proximity to NIST, NIH, FDA, Walter Reed, and the Naval Medical Research Center makes it an ideal location for cutting-edge research. The institute brings together researchers from two university partners who are prominent in these fields to explore how emerging technologies can facilitate knowledge discovery for human health and well-being.

The institute will catalyze a clinical data science ecosystem in North Bethesda that will draw FDA and NIH investigators, UMB and UMCP faculty, medical bioinformatics education programs and students, and industry partners, enabling the expansion of computational “dry” laboratories, virtual meeting rooms and classrooms.

Earlier this year, we reported how the University of Maryland School of Medicine expanded its telemedicine program to better reach patients and caregivers.

In March, we described how the Center for Tech Innovation at the University of Maryland Medical System/UMD School of Medicine created a custom secure messaging platform integrated into its EHR that uses a secure messaging API for flexibility and scalability.

Also Read :  Zhaoxin Launches KX-6000G High-Performance & KH-40000 Server CPUs For China's Domestic PC Market

“Our vision is for this to become the East Coast Silicon Valley for health computing. The goals of this new institute perfectly align with the University of Maryland School of Medicine’s new strategic vision to use disruptive technology and the power of clinical analysis entertain and nurture. precision medicine to improve patient care and provide population health services,” said Dr. Mark T. Gladwin, vice president for medical affairs at the University of Maryland, Baltimore.

“De-identified data from 1.8 million patients in our system together with clinical research data from UMB will provide the basis for advanced clinical analysis that will ultimately lead to faster diagnoses, improvements in how therapeutics are used and a number of other improved outcomes. for our patients, as well as patients around the world,” said Dr. Mohan Suntha, president and CEO of the University of Maryland Medical System.

Twitter: @MikeMiliardHITN
Email the writer: [email protected]

Healthcare IT News is a HIMSS publication.


Leave a Reply

Your email address will not be published.

Related Articles

Back to top button